We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $3.85B
1-Year Est. Return 32.11%
This Fund
S&P 500
This Quarter Est. Return
-15.72%
1 Year Est. Return
+32.11%
3 Year Est. Return
+93.86%
5 Year Est. Return
+112.79%
10 Year Est. Return
+380.9%
AUM
$4.46B
AUM Growth
-$6B
Cap. Flow
-$4.51B
Cap. Flow %
-101.07%
Top 10 Hldgs %
21.21%
Holding
7,134
New
733
Increased
2,939
Reduced
2,324
Closed
739

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$411M
2
MSFT icon
Microsoft
MSFT
+$372M
3
AMZN icon
Amazon
AMZN
+$192M
4
TSLA icon
Tesla
TSLA
+$121M
5
GOOG icon
Alphabet (Google) Class C
GOOG
+$111M

Sector Composition

Rank Sector Weight
1 Technology 22.54%
2 Healthcare 10.8%
3 Consumer Discretionary 9.19%
4 Financials 8.28%
5 Communication Services 7.91%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MIDU icon
2176
Direxion Daily Mid Cap Bull 3X ETF
MIDU
$78.9M
$116K ﹤0.01%
3,637
+3,025
+494% +$132K
WRBY icon
2177
Warby Parker
WRBY
$3.23B
$116K ﹤0.01%
+10,302
New +$207K
ICPT
2178
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
$116K ﹤0.01%
8,419
+4,457
+112% +$71.4K
CPSS icon
2179
Consumer Portfolio Services
CPSS
$203M
$115K ﹤0.01%
11,233
+10,015
+822% +$122K
CELH icon
2180
Celsius Holdings
CELH
$6.66B
$114K ﹤0.01%
5,247
-18,654
-78% -$360K
CRK icon
2181
Comstock Resources
CRK
$4.24B
$114K ﹤0.01%
9,416
+5,242
+126% +$86.7K
IRTC icon
2182
iRhythm Holdings
IRTC
$4.11B
$114K ﹤0.01%
1,057
-2,361
-69% -$313K
ITOS
2183
DELISTED
iTeos Therapeutics
ITOS
$114K ﹤0.01%
5,527
-328
-6% -$7.78K
NPO icon
2184
Enpro
NPO
$7.03B
$114K ﹤0.01%
1,389
+1,190
+598% +$111K
CYBR
2185
DELISTED
CyberArk
CYBR
$113K ﹤0.01%
881
+880
+88,000% +$127K
GTY
2186
Getty Realty Corp
GTY
$2.01B
$113K ﹤0.01%
4,253
+3,950
+1,304% +$107K
KRE icon
2187
State Street SPDR S&P Regional Banking ETF
KRE
$4.55B
$113K ﹤0.01%
1,944
-18,497
-90% -$1.16M
UTI icon
2188
Universal Technical Institute
UTI
$1.49B
$113K ﹤0.01%
15,776
+10,834
+219% +$95.5K
BNFT
2189
DELISTED
Benefitfocus, Inc.
BNFT
$113K ﹤0.01%
14,470
+13,480
+1,362% +$133K
ALIT icon
2190
Alight
ALIT
$389M
$112K ﹤0.01%
834
+665
+393% +$109K
ARCT icon
2191
Arcturus Therapeutics
ARCT
$199M
$112K ﹤0.01%
7,130
+6,795
+2,028% +$133K
ATEX icon
2192
Anterix
ATEX
$1.81B
$112K ﹤0.01%
2,734
+2,613
+2,160% +$127K
COUR icon
2193
Coursera
COUR
$1.53B
$112K ﹤0.01%
7,866
+1,121
+17% +$20K
EWZ icon
2194
iShares MSCI Brazil ETF
EWZ
$8.91B
$112K ﹤0.01%
4,090
-948
-19% -$31.4K
PD icon
2195
PagerDuty
PD
$919M
$112K ﹤0.01%
4,528
-9,192
-67% -$252K
SMBK icon
2196
SmartFinancial
SMBK
$879M
$112K ﹤0.01%
4,614
+3,581
+347% +$89K
BECN
2197
DELISTED
Beacon Roofing Supply, Inc.
BECN
$112K ﹤0.01%
2,193
-3,263
-60% -$191K
MNKD icon
2198
MannKind Corp
MNKD
$1.25B
$111K ﹤0.01%
29,120
+11,170
+62% +$41K
PATK icon
2199
Patrick Industries
PATK
$2.71B
$111K ﹤0.01%
3,231
+1,789
+124% +$70.8K
SNDX icon
2200
Syndax Pharmaceuticals
SNDX
$1.81B
$111K ﹤0.01%
5,745
+3,434
+149% +$57.2K

Similar funds

Tower Research Capital (TRC)'s Q2 2022 Portfolio in Review

As of Q2 2022, Tower Research Capital (TRC) held 7,134 positions worth $4.46B, down 57% from $10.5B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Tower Research Capital (TRC) withdrew a net $4.51B in Q2 2022, closing 739 positions and reducing 2,324 holdings. Its most notable exit was iShares MSCI USA Value Factor ETF, an estimated $13.8M position sold in full.

By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 31% a quarter earlier, followed by Healthcare and Consumer Discretionary.

Against the trend, Tower Research Capital (TRC) opened a new position in iShares Russell 1000 Value ETF worth $23.4M.

  • Tower Research Capital (TRC)'s largest Q2 2022 buy was iShares Russell 1000 Value ETF: 161,690 shares worth $23.4M.
  • Tower Research Capital (TRC) added most to iShares Russell 2000 ETF in Q2 2022, an estimated $41.1M increase.
  • Tower Research Capital (TRC)'s biggest Q2 2022 reduction was Apple, cutting an estimated $411M.
  • Tower Research Capital (TRC) fully exited iShares MSCI USA Value Factor ETF in Q2 2022, selling an estimated $13.8M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 21% of its $4.46B portfolio in Q2 2022.
  • Tower Research Capital (TRC) opened 733 new positions and closed 739 in Q2 2022.
  • Tower Research Capital (TRC)'s portfolio value fell 57% quarter-over-quarter to $4.46B.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2022, filed 15 Aug 2022.